Theratechnologies Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Theratechnologies Inc. with three other
companies in this sector in Canada:
Cardiome Pharma Corp.
sales of 26.93 million Canadian Dollars [US$20.30 million]
of which 100%
was Pharma Product Development),
Acerus Pharmaceuticals Corporation
(21.79 million Canadian Dollars [US$16.42 million]
Nuvo Pharmaceuticals Inc
(21.35 million Canadian Dollars [US$16.09 million]
of which 96%
was Nuvo Pharma).
Sales increased substantially in 2015:
During the year ended November of 2015, sales at
Theratechnologies Inc. were C$30.06 million (US$22.65 million).
increase of 346.4%
versus 2014, when the company's sales were C$6.73 million.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Theratechnologies Inc. had sales
of C$31.87 million.